Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors

This publication has 45 references indexed in Scilit:

• Impact of Tamoxifen on Amount of Fibroglandular Tissue, Background Parenchymal Enhancement, and Cysts on Breast Magnetic Resonance Imaging
  The Breast Journal, 2012
• Should breast MRI be performed with adjustment for the phase in patients’ menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients’ menstrual cycle
  European Journal of Radiology, 2012
• Reasons Women at Elevated Risk of Breast Cancer Refuse Breast MR Imaging Screening: ACRIN 6666
  Radiology, 2010
• Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort
  Magnetic Resonance Imaging, 2010
• Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study
  Breast Cancer Research, 2009
• Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study
  The Lancet Oncology, 2009
• Accuracy of Assigned BI-RADS Breast Density Category Definitions
  Academic Radiology, 2006
• Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis
  Cancer Epidemiology, Biomarkers & Prevention, 2006
• Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories
  The Breast, 2005
• Physiologic Changes in Breast Magnetic Resonance Imaging during the Menstrual Cycle: Perfusion Imaging, Signal Enhancement, and Influence of the T1 Relaxation Time of Breast Tissue
  The Breast Journal, 2005